Latest news
Weekly Recap: Q2 revenue and guidance and Phase III clinical timelines - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTBiogen's Q2 Earnings Beat, New Drugs Drive Sales, 2026 Guidance Raised - TradingViewTradingView · Wed, 29 Jul 2026 15:09:00 GMTBiogen (NASDAQ:BIIB) Reports Upbeat Q2 CY2026 - TradingViewTradingView · Wed, 29 Jul 2026 12:15:45 GMTBiogen reports Q2 2026: $2.74B revenue, GAAP EPS $0.66, Non‑GAAP EPS $3.60 - TradingViewTradingView · Wed, 29 Jul 2026 10:13:01 GMTBiogen Inc. Stock 12‑Month Price Target Raised to $231.82, Implies 13% Upside - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMTBiogen 2026: Revenue $2.74B, EPS $0.66— 10-Q Summary - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMTBiogen Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMTBiogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of Earnings - TradingViewTradingView · Mon, 27 Jul 2026 07:00:00 GMT